Latinos are 1.5 times more likely to develop Alzheimer’s than their white peers. Its why diversity in clinical trials is absolutely critical. Fortunately, those studies can help us fight back against Alzheimer’s. If you are age 55 to 80, you can volunteer for the AHEAD Clinical Trial that aims to protect against the onset of Alzheimer's disease, led by the experts at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio. “I got involved with the AHEAD clinical trial because both of my parents had Alzheimer’s,” Dave Ralberer, an AHEAD study participant and study partner, said. “My mother was 72 when she passed away. My dad has been struggling with the disease for 13 years. I have the unusual opportunity to be working with ...
El cáncer es un camino difícil, miedoso y peligroso para la vida, especialmente para las mujeres de color. Por esto es que los investigadores realizan estudios clínicos, que son estudios para encontrar tratamientos más efectivos o para lograr un mejor entendimiento del cáncer de seno y la supervivencia en las minorías. Pero, para progresar, los estudios clínicos necesitan voluntarios diversos, como Elsada Wilson. Wilson participó en un estudio clínico del Mays Cancer Center de UT Health San Antonio y encontró esperanza para ella, su familia y el futuro. "Sentí que estaba ayudando a avanzar los estudios y el conocimiento", dijo. "Si me ayuda, entonces podré ayudar a mi familia y ayudar a otras personas que necesitan ayuda. Quería ayudar a los demás. Me dije a mí ...
Doctors have implicit, subconscious preferences for white patients over those of color, studies show. This is implicit bias. These biases — stereotypes that affect our understanding and decisions about others beyond our conscious control — lead to discrimination and health disparities. Fortunately, implicit bias can be “rewired” for compassion for patients of color. Download the free Salud America! Action Pack “Health Care Workers and Researchers: Find If You Have Implicit Bias and What to Do Next.” "This Action Pack will help you see if you have implicit bias, learn from others who have overcome their own implicit bias, and encourage colleagues to learn about implicit bias, too," said Dr. Amelie G. Ramirez, director of the Salud America! Latino health equity ...
Why did Emelina Asto-Flores volunteer for a clinical trial to test a COVID-19 vaccine? Asto-Flores, a community health educator in Florida, saw how the pandemic devastated Latinos, and she decided to enroll in the trial to help her people. Not only did she help researchers make sure the vaccine is safe for Latinos, but the trial also gave her the knowledge and confidence to encourage others to get their shot. “Representation is important in a clinical trial,” Asto-Flores said. “You wouldn't want a clinical trial to be just consisted of one group. These results need to be proportionate to our diverse communities. It's so important for us as members of the [Latino] community to take that leadership role that could save lives. So those that are a part of that can say, ...
Alzheimer’s disease hurts the quality of life of many of our beloved abuelos and abuelas, their family members, and caregivers. Fortunately, clinical trials can help us fight back against Alzheimer’s. You or your loved ones can volunteer for the REACH Clinical Trial that aims to slow the effects of Alzheimer’s disease, led by the experts at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio. REACH Clinical Trial volunteers will be reimbursed up to $100 for each trial visit. “Our mission is to provide a compassionate and comprehensive network of clinical care for patients and their families with access to the most advanced treatment in clinical trials, as we continue to lead the search for a cure for Alzheimer’s and ...
Latinos spend $7,167 a year caring for aging loved ones, says an AARP survey. While this is actually less than what Whites caregivers spend out of pocket a year ($7,300), the financial strain is greater because it represents almost half the income of Latino caregivers, according to the report. Currently, over 48 million Americans provide unpaid care to an adult family member or friend who has a physical health condition or a mental health issue like Alzheimer's and dementia. Most caregivers say they use their own money to look after their loved ones, like rent or mortgage payments, home modifications like wheelchair ramps, and medical costs. "About half of caregivers say they have experienced financial setbacks. This may mean they have had to curtail their spending, dip into ...
We know Latinos are 1.5 times more likely to develop Alzheimer’s disease and dementia than whites. Now a new study shows that Latinos experience slightly different signs and symptoms of dementia, with more depression and anxiety and a faster rate of functional decline than Blacks or non-Hispanic Whites, AARP reports. Anxiety and depression are risk factors for dementia. Studies have suggested anxiety and depression can cause early manifestations of abnormal protein accumulations in the brain — amyloid and tau — which lead to dementia. In the new study of 5,000 people, researchers found more anxiety among Latinos (25.6 %) than Blacks (16.3 %) or Whites (11.3 %). "We need to do a better job of making mental health services accessible for these groups, with culturally ...
The U.S. Food and Drug Administration approved a new drug called Aduhelm (aducanumab) to treat Alzheimer’s disease, the most common form of dementia. Many are applauding the drug and are encouraged by the scientific progress in a field that has long had limited treatment options. Alzheimer’s affects over 6.2 million people in the U.S., with Latinos being 1.5 times more likely to develop it than white people. “What's really exciting is that aducanumab is the first new FDA-approved Alzheimer's treatment in nearly 20 years, and we're optimistic this will spark a wave of new research and innovation in this space. Patients are excited for that, too, and if aducanumab is the first step toward that brighter future, patients are eager to be part of it,” said Dr. Rany Aburashed, ...
Latinos with cancer face a tough survivorship journey. Many suffer advanced disease, poor quality of life, and stressful social and economic inequities. This is why a new, first-of-its-kind national cohort study will unpack the social, cultural, behavioral, psychosocial, biological, and medical influences on post-cancer life in Latino cancer survivors to fill a crucial gap in knowledge about their survivorship experience. The study, “Avanzando Caminos (Leading Pathways): The Hispanic/Latino Cancer Survivorship Study,” is funded by a 6-year, $9.8-million grant from the National Cancer Institute that will team up two of its Cancer Centers, the Mays Cancer Center, home to UT Health San Antonio MD Anderson and the Sylvester Comprehensive Cancer Center at the University of ...
